Not checkedNot checked for notices yet.
Chemsex must not be overlooked in Europe’s HIV prevention strategy
Tiffany E. Gooden, Gary Whitlock
The Lancet Regional Health. Europe · 2025
doi:10.1016/j.lanepe.2025.101423 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Chemsex has emerged as a public health concern in Europe, due to its association with increased HIV transmission and other sexually transmitted infections (STIs).1 Chemsex typically refers to the use of drugs such as crystal methamphetamine, mephedrone and gamma-hydroxybutyrate (GHB)/gamma-butyrolactone (GBL) to facilitate or enhance sex. Chemsex is often associated with gay and bisexual men who have sex with men (GBMSM), though chemsex also occurs among other LGBTQ + groups and is increasingly reported among heterosexual cis women and men.
Abstract licence: CC BY-NC-ND
References7
7 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.